While the US tariffs on China might seem beneficial to India, Jigar Mistry of Buoyant Capital warns of potential trade displacement. China may flood other markets, including India, with exports, creating challenges. Mistry emphasizes that the situation is nuanced, requiring a calibrated approach, as global slowdown fears impact crude oil and the dollar, affecting India’s macro outlook.
Pharma stocks rally up to 4%, but will Trump order really have minimal impact?
The Nifty Pharma index gained around 2% on Tuesday, defying the broader market trend, as the Nifty slipped nearly 0.5% amid profit-booking following Monday’s sharp
May 13, 2025